<p>(A) Starch-modified (ST) magnetite nanoparticles (mNP) or (B) Phosphatidylcholine-modified (PL) mNPs (1.532×10<sup>10</sup>/ml) were exposed to alveolar macrophages in the absence or presence of increasing surfactant protein concentrations and incubated for 90 min. Cells with Fl-1>10<sup>1</sup> were considered as positive cells for nanoparticle association and uptake (expressed as percent of positive cells with respect to total cells) compared to control (cells only). Data shown as mean ± SD (n≥3). Asterisk indicates a significant difference with p<0.05, compared to mNP in the absence of proteins.</p
[[abstract]]Magnetic nanoparticles (MNPs) are few of the nanoparticles used clinically. When MNPs ar...
The alveolar lining fluid (ALF) covering the respiratory epithelium of the deep lung is the first bi...
Optical microscopy (OM), semi-contact atomic force microscopy (sc-AFM), and transmission electron mi...
<p>Starch- (ST) or Phosphatidylcholine-modified (PL) magnetite nanoparticles (mNP; 1.532×10<sup>10</...
<p>(A) Starch- (ST) or Phosphatidylcholine-modified (PL) magnetite nanoparticles (mNP; 1.532×10<sup>...
<p>(A) Starch- (ST) or Phosphatidylcholine-modified (PL) magnetite nanoparticles (mNP; 1.532×10<sup>...
<p>Representative micrographs are shown for Starch-modified (ST) magnetite nanoparticles (mNP) (A, C...
The peripheral lungs are a potential entrance portal for nanoparticles into the human body due to th...
<div><p>The peripheral lungs are a potential entrance portal for nanoparticles into the human body d...
Numerous epidemiological and toxicological studies have associated enhanced exposure to ambient air ...
Aim: To investigate the interaction behavior of M1- and M2-type macrophages with nanoparticles of di...
Surfactant protein A (SP-A), a lung anti-infective protein, is a lectin with affinity for sugars fou...
The lung provides the main route for nanomaterial exposure. Surfactant protein A (SP-A) is an import...
<div><p></p><p>The lung provides the main route for nanomaterial exposure. Surfactant protein A (SP-...
Magnetic nanoparticles (MNPs) are few of the nanoparticles used clinically. When MNPs are delivered ...
[[abstract]]Magnetic nanoparticles (MNPs) are few of the nanoparticles used clinically. When MNPs ar...
The alveolar lining fluid (ALF) covering the respiratory epithelium of the deep lung is the first bi...
Optical microscopy (OM), semi-contact atomic force microscopy (sc-AFM), and transmission electron mi...
<p>Starch- (ST) or Phosphatidylcholine-modified (PL) magnetite nanoparticles (mNP; 1.532×10<sup>10</...
<p>(A) Starch- (ST) or Phosphatidylcholine-modified (PL) magnetite nanoparticles (mNP; 1.532×10<sup>...
<p>(A) Starch- (ST) or Phosphatidylcholine-modified (PL) magnetite nanoparticles (mNP; 1.532×10<sup>...
<p>Representative micrographs are shown for Starch-modified (ST) magnetite nanoparticles (mNP) (A, C...
The peripheral lungs are a potential entrance portal for nanoparticles into the human body due to th...
<div><p>The peripheral lungs are a potential entrance portal for nanoparticles into the human body d...
Numerous epidemiological and toxicological studies have associated enhanced exposure to ambient air ...
Aim: To investigate the interaction behavior of M1- and M2-type macrophages with nanoparticles of di...
Surfactant protein A (SP-A), a lung anti-infective protein, is a lectin with affinity for sugars fou...
The lung provides the main route for nanomaterial exposure. Surfactant protein A (SP-A) is an import...
<div><p></p><p>The lung provides the main route for nanomaterial exposure. Surfactant protein A (SP-...
Magnetic nanoparticles (MNPs) are few of the nanoparticles used clinically. When MNPs are delivered ...
[[abstract]]Magnetic nanoparticles (MNPs) are few of the nanoparticles used clinically. When MNPs ar...
The alveolar lining fluid (ALF) covering the respiratory epithelium of the deep lung is the first bi...
Optical microscopy (OM), semi-contact atomic force microscopy (sc-AFM), and transmission electron mi...